Applications of deuterium labelling in pharmacokinetic and concentration-effect studies of clonidine
- 1 January 1978
- book chapter
- Published by Springer Nature
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Pharmacokinetics and concentration‐effect relationships of intravenous and oral clonidineClinical Pharmacology & Therapeutics, 1977
- The central hypotensive effect of clonidine; Studies in tetraplegie subjcetsClinical Pharmacology & Therapeutics, 1977
- Apparent resistance to hypotensive effect of clonidine.BMJ, 1977
- Clinical pharmacology and pharmacokinetics of clonidineClinical Pharmacology & Therapeutics, 1976
- Intravenous clonidine in hypertensive patientsClinical Pharmacology & Therapeutics, 1973
- Localization of the hypotensive effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, catapresan)European Journal of Pharmacology, 1969
- The physiological disposition of 2-(2,6-dichloroanilino)-2-imidazoline (St-155)Biochemical Pharmacology, 1969
- Some observations on the inhibition of salivation by St 155 [2-(2,5-dichlorophenylamine)-2-imidazoline hydrochloride, Catapres®, Catapresan®]European Journal of Pharmacology, 1969
- Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HClEuropean Journal of Pharmacology, 1967